FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016366979> ?p ?o ?g. }

• W2016366979 endingPage "1240" @default.
• W2016366979 startingPage "1233" @default.
• W2016366979 abstract "The prevalence of drug-resistant bacteria drives the quest for new antimicrobials, including those that are not expected to readily engender resistance. One option is to mimic Nature's most ubiquitous means of controlling bacterial growth, antimicrobial peptides, which have evolved over eons. In general, bacteria remain susceptible to these peptides. Human antimicrobial peptides play a central role in innate immunity, and deficiencies in these peptides have been tied to increased rates of infection. However, clinical use of antimicrobial peptides is hampered by issues of cost and stability. The development of nonpeptide mimics of antimicrobial peptides may provide the best of both worlds: a means of using the same mechanism chosen by Nature to control bacterial growth without the problems associated with peptide therapeutics. The ceragenins were developed to mimic the cationic, facially amphiphilic structures of most antimicrobial peptides. These compounds reproduce the required morphology using a bile-acid scaffolding and appended amine groups. The resulting compounds are actively bactericidal against both gram-positive and gram-negative organisms, including drug-resistant bacteria. This antimicrobial activity originates from selective association of the ceragenins with negatively charged bacterial membrane components. Association has been studied with synthetic models of bacterial membrane components, with bacterial lipopolysaccharide, with vesicles derived from bacterial phospholipids, and with whole cells. Comparisons of the antimicrobial activities of ceragenins and representative antimicrobial peptides suggest that these classes of compounds share a mechanism of action. Rapid membrane depolarization is caused by both classes as well as blebbing of bacterial membranes. Bacteria express the same genes in response to both classes of compounds. On the basis of the antibacterial activities of ceragenins and preliminary in vivo studies, we expect these compounds to find use in augmenting or replacing antimicrobial peptides in treating human disease." @default.
• W2016366979 created "2016-06-24" @default.
• W2016366979 creator A5020782718 @default.
• W2016366979 creator A5022025225 @default.
• W2016366979 creator A5030953137 @default.
• W2016366979 creator A5038078731 @default.
• W2016366979 creator A5046086498 @default.
• W2016366979 creator A5049367780 @default.
• W2016366979 creator A5084829703 @default.
• W2016366979 creator A5087099205 @default.
• W2016366979 date "2008-07-11" @default.
• W2016366979 modified "2023-10-01" @default.
• W2016366979 title "Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides" @default.
• W2016366979 cites W1964894938 @default.
• W2016366979 cites W1968125869 @default.
• W2016366979 cites W1976038226 @default.
• W2016366979 cites W1981456994 @default.
• W2016366979 cites W1985095637 @default.
• W2016366979 cites W1998751682 @default.
• W2016366979 cites W2002066211 @default.
• W2016366979 cites W2003897459 @default.
• W2016366979 cites W2025213109 @default.
• W2016366979 cites W2030317588 @default.
• W2016366979 cites W2042656577 @default.
• W2016366979 cites W2048858553 @default.
• W2016366979 cites W2060483617 @default.
• W2016366979 cites W2062263518 @default.
• W2016366979 cites W2069865281 @default.
• W2016366979 cites W2070847413 @default.
• W2016366979 cites W2085136523 @default.
• W2016366979 cites W2085456770 @default.
• W2016366979 cites W2088594795 @default.
• W2016366979 cites W2094097979 @default.
• W2016366979 cites W2129003791 @default.
• W2016366979 cites W2131293938 @default.
• W2016366979 cites W2143331022 @default.
• W2016366979 cites W2143672576 @default.
• W2016366979 cites W2147923089 @default.
• W2016366979 cites W2155972568 @default.
• W2016366979 cites W2156233344 @default.
• W2016366979 cites W2159358925 @default.
• W2016366979 cites W2159861471 @default.
• W2016366979 cites W2161180045 @default.
• W2016366979 cites W2164257879 @default.
• W2016366979 cites W2951568312 @default.
• W2016366979 cites W4255641582 @default.
• W2016366979 doi "https://doi.org/10.1021/ar700270t" @default.
• W2016366979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18616297" @default.
• W2016366979 hasPublicationYear "2008" @default.
• W2016366979 type Work @default.
• W2016366979 sameAs 2016366979 @default.
• W2016366979 citedByCount "176" @default.
• W2016366979 countsByYear W20163669792012 @default.
• W2016366979 countsByYear W20163669792013 @default.
• W2016366979 countsByYear W20163669792014 @default.
• W2016366979 countsByYear W20163669792015 @default.
• W2016366979 countsByYear W20163669792016 @default.
• W2016366979 countsByYear W20163669792017 @default.
• W2016366979 countsByYear W20163669792018 @default.
• W2016366979 countsByYear W20163669792019 @default.
• W2016366979 countsByYear W20163669792020 @default.
• W2016366979 countsByYear W20163669792021 @default.
• W2016366979 countsByYear W20163669792022 @default.
• W2016366979 countsByYear W20163669792023 @default.
• W2016366979 crossrefType "journal-article" @default.
• W2016366979 hasAuthorship W2016366979A5020782718 @default.
• W2016366979 hasAuthorship W2016366979A5022025225 @default.
• W2016366979 hasAuthorship W2016366979A5030953137 @default.
• W2016366979 hasAuthorship W2016366979A5038078731 @default.
• W2016366979 hasAuthorship W2016366979A5046086498 @default.
• W2016366979 hasAuthorship W2016366979A5049367780 @default.
• W2016366979 hasAuthorship W2016366979A5084829703 @default.
• W2016366979 hasAuthorship W2016366979A5087099205 @default.
• W2016366979 hasConcept C15920480 @default.
• W2016366979 hasConcept C178790620 @default.
• W2016366979 hasConcept C185592680 @default.
• W2016366979 hasConcept C2775900799 @default.
• W2016366979 hasConcept C2779281246 @default.
• W2016366979 hasConcept C2779399885 @default.
• W2016366979 hasConcept C4937899 @default.
• W2016366979 hasConcept C521977710 @default.
• W2016366979 hasConcept C523546767 @default.
• W2016366979 hasConcept C540938839 @default.
• W2016366979 hasConcept C54355233 @default.
• W2016366979 hasConcept C55493867 @default.
• W2016366979 hasConcept C67407626 @default.
• W2016366979 hasConcept C86803240 @default.
• W2016366979 hasConcept C89423630 @default.
• W2016366979 hasConceptScore W2016366979C15920480 @default.
• W2016366979 hasConceptScore W2016366979C178790620 @default.
• W2016366979 hasConceptScore W2016366979C185592680 @default.
• W2016366979 hasConceptScore W2016366979C2775900799 @default.
• W2016366979 hasConceptScore W2016366979C2779281246 @default.
• W2016366979 hasConceptScore W2016366979C2779399885 @default.
• W2016366979 hasConceptScore W2016366979C4937899 @default.
• W2016366979 hasConceptScore W2016366979C521977710 @default.
• W2016366979 hasConceptScore W2016366979C523546767 @default.
• W2016366979 hasConceptScore W2016366979C540938839 @default.

• next